Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma
Open Access
- 1 April 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (4) , 379-383
- https://doi.org/10.1023/a:1008228709612
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low‐grade non‐Hodgkin's lymphomaEuropean Journal of Haematology, 1995
- 2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1994
- Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaAnnals of Oncology, 1993
- Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non- Hodgkin's lymphomaBlood, 1993
- Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.Journal of Clinical Oncology, 1992
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.Journal of Clinical Oncology, 1989
- Stage I-II follicular lymphoma: Treatment results for 76 patientsCancer, 1986
- Prognostic factors in nodular lymphomas: A multivariate analysis based on the Princess Margaret Hospital experienceInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and IICancer, 1983